Marvell Technology Stock Rises 3.7% in Premarket Trading Following Barclays Upgrade to Overweight from Equal-Weight
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 09 2026
0mins
Should l Buy MRVL?
Source: moomoo
Market Movement: Marvel Technology shares increased by 3.7% in pre-market trading.
Analyst Upgrade: Barclays upgraded Marvel Technology's rating from equal-weight to overweight.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MRVL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MRVL
Wall Street analysts forecast MRVL stock price to fall
30 Analyst Rating
22 Buy
8 Hold
0 Sell
Moderate Buy
Current: 147.840
Low
85.00
Averages
120.12
High
156.00
Current: 147.840
Low
85.00
Averages
120.12
High
156.00
About MRVL
Marvell Technology, Inc., together with its subsidiaries, is a supplier of data infrastructure semiconductor solutions, spanning the data center core to network edge. The Company is engaged in the design, development, and sale of integrated circuits. Its product solutions serve various end markets: data center, enterprise networking, carrier infrastructure, consumer, and industrial. Its product offerings include CXL, Data Processing Units, Security Solutions, Coherent DSPs, Coherent-lite DSPs, Data Center Switches, DCI Optical Modules, Enterprise Switches, Ethernet Controllers, Ethernet PHYs, PCIe Retimers, Linear Drivers, PAM DSPs, Transimpedance Amplifiers, Fiber Channel, HDD, Storage Accelerators, and SSD Controllers. The Company develops semiconductor solutions tailored to individual customer specifications that deliver system-level differentiation for artificial intelligence, data center, compute, networking, carrier, storage, aerospace, and defense applications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
POET Confirms Business Relationship with Marvell for the First Time
- Stock Surge: POET shares rallied 7% in overnight trading ahead of Wednesday, marking a total increase of approximately 40% over the past two days, reflecting strong market interest in its photonics technology amid rapid data center buildouts.
- Optimistic Order Outlook: CFO Thomas Mika disclosed that POET has received a purchase order linked to Marvell Technology and anticipates that this year's orders will be 'far in excess' of the previously disclosed $5 million order, indicating increased confidence in manufacturing capabilities.
- Shift in Market Sentiment: Following Mika's interview, retail sentiment for POET on Stocktwits surged from 'bullish' to 'extremely bullish', with message volume increasing nearly 50% in the past 24 hours, showcasing investor optimism about the company's future prospects.
- Industry Partnership Confirmation: POET's partnership with Celestial AI, which began in 2022, was highlighted as Marvell recently acquired Celestial AI; this marks the first confirmation of POET's business relationship with Marvell, solidifying its role as a key supplier in the photonic chip platform.
See More
POET Stock Surges 20% After CFO Dismisses Short Seller Report
- POET Stock Surge: Following CFO Thomas Mika's dismissal of Wolfpack Research's short report, POET stock surged over 20% to $11.09 during trading, reflecting strong investor confidence in the company's outlook and likely attracting further investor interest.
- MRVL Continues Rally: Marvell Technology's stock rose for the third consecutive day, reaching $154.95, driven by optimism surrounding a potential deal with Google and an upward price target revision from RBC Capital from $115 to $170, indicating increased market confidence in its future growth.
- BE Price Target Hikes: Bloom Energy's shares climbed after receiving price target increases from UBS and Citi, with UBS raising its target from $170 to $251 and Citi from $162 to $229, reflecting market recognition of its potential in AI demand and high-density computing capabilities.
- Strong Retail Sentiment: On Stocktwits, retail sentiment for both POET and MRVL stocks was in the 'extremely bullish' territory, indicating strong optimism among investors, which is expected to drive their stock prices higher in the near future.
See More
Trump Extends Iran Ceasefire Deadline Amid Market Uncertainty
- Ceasefire Extension: President Trump has extended the Iran ceasefire deadline by two weeks, a move that may exacerbate uncertainty in the Middle East conflict as Tehran shows reluctance to engage in diplomatic efforts, potentially impacting global market sentiment.
- Tariff Policy Impact: Trump expressed hope that U.S. companies that have not sought refunds for his tariffs will adhere to a 'no take back' policy, despite the Supreme Court ruling the tariffs illegal; major firms like Apple and Amazon have yet to file for refunds, which could affect their future financial performance.
- Market Reaction: Following Trump's announcement of the ceasefire extension, U.S. stock index futures rose, despite a lower close on Tuesday, while crude oil prices increased, indicating market sensitivity to developments in the Middle East.
- Aviation Industry Outlook: United Airlines has slashed its 2026 earnings outlook due to supply chain issues stemming from the Middle East conflict, reflecting the direct impact of soaring fuel prices on the airline industry and potentially leading to broader industry adjustments.
See More
US Stocks Rise on Strong Retail Sales and Earnings Reports
- Strong Retail Sales: US March retail sales rose 1.7% month-over-month, exceeding expectations of 1.4% and marking the largest increase in a year, indicating robust consumer spending that could bolster economic recovery and market confidence.
- Earnings Support: UnitedHealth Group (UNH) reported Q1 adjusted EPS of $9.23, significantly above the consensus of $6.57, raising its full-year forecast to above $18.25, which has driven health insurance stocks higher and reflects industry resilience.
- Fed Nomination in Focus: Kevin Warsh's confirmation hearing before the Senate Banking Committee is drawing attention; despite facing an investigation hurdle, Warsh's commitment to an independent Fed and prioritizing inflation control could influence future monetary policy directions.
- International Tensions Impact Oil Prices: WTI crude oil prices fell over 1% as Iran is set to attend peace talks with the US, while the closure of the Strait of Hormuz threatens to exacerbate the global energy crisis, affecting market sentiment.
See More
U.S. Stocks Mixed as Oil Prices Rebound
- Market Performance: The S&P 500 Index fell by 0.13%, and the Dow Jones Industrial Average also declined by 0.13%, while the Nasdaq 100 saw a slight increase of 0.02%, reflecting market volatility influenced by oil price rebounds and economic data.
- Strong Economic Data: March retail sales rose by 1.7% month-over-month, exceeding expectations of 1.4%, marking the largest increase in a year, indicating robust consumer spending that may support stock prices.
- Oil Price Recovery: WTI crude oil prices rebounded by over 2% as market speculation intensified regarding Iran's participation in upcoming peace talks, potentially exacerbating the global energy crisis.
- Impressive Earnings Reports: UnitedHealth Group reported Q1 adjusted EPS of $9.23, significantly above the consensus of $6.57, leading to a stock price increase of over 7% and raising its full-year earnings forecast, showcasing strong performance in the health insurance sector.
See More
Marvell Technology to Benefit from Amazon-Anthropic Partnership Expansion
- Investment Scale: Anthropic announced it will invest over $100 billion in Amazon Web Services over the next decade to support the training and operation of its Claude large language models, aiming to secure up to 5 gigawatts of new capacity, significantly enhancing its competitive edge in AI technology.
- Key Role of Marvell: As a long-standing partner for Amazon's Trainium chips, Marvell supplies optical processors and other hardware, with analysts noting that the ramp-up of Trainium 3 will enhance Marvell's potential gains in Trainium 4, driving future growth for the company.
- Price Target Increase: RBC Capital Markets raised Marvell's price target from $115 to $170, reflecting optimistic market expectations for increased demand in AI chips and data center hardware, with current stock trading around $150, indicating strong market confidence.
- AI Market Outlook: With Anthropic's commitment to Amazon, demand for Marvell's ethernet switches and data processing units is expected to surge, and analysts believe this will lead to robust double-digit growth momentum, further solidifying its position in the AI hardware market.
See More
POET Confirms Business Relationship with Marvell for the First Time
- Stock Surge: POET shares rallied 7% in overnight trading ahead of Wednesday, marking a total increase of approximately 40% over the past two days, reflecting strong market interest in its photonics technology amid rapid data center buildouts.
- Optimistic Order Outlook: CFO Thomas Mika disclosed that POET has received a purchase order linked to Marvell Technology and anticipates that this year's orders will be 'far in excess' of the previously disclosed $5 million order, indicating increased confidence in manufacturing capabilities.
- Shift in Market Sentiment: Following Mika's interview, retail sentiment for POET on Stocktwits surged from 'bullish' to 'extremely bullish', with message volume increasing nearly 50% in the past 24 hours, showcasing investor optimism about the company's future prospects.
- Industry Partnership Confirmation: POET's partnership with Celestial AI, which began in 2022, was highlighted as Marvell recently acquired Celestial AI; this marks the first confirmation of POET's business relationship with Marvell, solidifying its role as a key supplier in the photonic chip platform.
See More
POET Stock Surges 20% After CFO Dismisses Short Seller Report
- POET Stock Surge: Following CFO Thomas Mika's dismissal of Wolfpack Research's short report, POET stock surged over 20% to $11.09 during trading, reflecting strong investor confidence in the company's outlook and likely attracting further investor interest.
- MRVL Continues Rally: Marvell Technology's stock rose for the third consecutive day, reaching $154.95, driven by optimism surrounding a potential deal with Google and an upward price target revision from RBC Capital from $115 to $170, indicating increased market confidence in its future growth.
- BE Price Target Hikes: Bloom Energy's shares climbed after receiving price target increases from UBS and Citi, with UBS raising its target from $170 to $251 and Citi from $162 to $229, reflecting market recognition of its potential in AI demand and high-density computing capabilities.
- Strong Retail Sentiment: On Stocktwits, retail sentiment for both POET and MRVL stocks was in the 'extremely bullish' territory, indicating strong optimism among investors, which is expected to drive their stock prices higher in the near future.
See More
Trump Extends Iran Ceasefire Deadline Amid Market Uncertainty
- Ceasefire Extension: President Trump has extended the Iran ceasefire deadline by two weeks, a move that may exacerbate uncertainty in the Middle East conflict as Tehran shows reluctance to engage in diplomatic efforts, potentially impacting global market sentiment.
- Tariff Policy Impact: Trump expressed hope that U.S. companies that have not sought refunds for his tariffs will adhere to a 'no take back' policy, despite the Supreme Court ruling the tariffs illegal; major firms like Apple and Amazon have yet to file for refunds, which could affect their future financial performance.
- Market Reaction: Following Trump's announcement of the ceasefire extension, U.S. stock index futures rose, despite a lower close on Tuesday, while crude oil prices increased, indicating market sensitivity to developments in the Middle East.
- Aviation Industry Outlook: United Airlines has slashed its 2026 earnings outlook due to supply chain issues stemming from the Middle East conflict, reflecting the direct impact of soaring fuel prices on the airline industry and potentially leading to broader industry adjustments.
See More
US Stocks Rise on Strong Retail Sales and Earnings Reports
- Strong Retail Sales: US March retail sales rose 1.7% month-over-month, exceeding expectations of 1.4% and marking the largest increase in a year, indicating robust consumer spending that could bolster economic recovery and market confidence.
- Earnings Support: UnitedHealth Group (UNH) reported Q1 adjusted EPS of $9.23, significantly above the consensus of $6.57, raising its full-year forecast to above $18.25, which has driven health insurance stocks higher and reflects industry resilience.
- Fed Nomination in Focus: Kevin Warsh's confirmation hearing before the Senate Banking Committee is drawing attention; despite facing an investigation hurdle, Warsh's commitment to an independent Fed and prioritizing inflation control could influence future monetary policy directions.
- International Tensions Impact Oil Prices: WTI crude oil prices fell over 1% as Iran is set to attend peace talks with the US, while the closure of the Strait of Hormuz threatens to exacerbate the global energy crisis, affecting market sentiment.
See More
U.S. Stocks Mixed as Oil Prices Rebound
- Market Performance: The S&P 500 Index fell by 0.13%, and the Dow Jones Industrial Average also declined by 0.13%, while the Nasdaq 100 saw a slight increase of 0.02%, reflecting market volatility influenced by oil price rebounds and economic data.
- Strong Economic Data: March retail sales rose by 1.7% month-over-month, exceeding expectations of 1.4%, marking the largest increase in a year, indicating robust consumer spending that may support stock prices.
- Oil Price Recovery: WTI crude oil prices rebounded by over 2% as market speculation intensified regarding Iran's participation in upcoming peace talks, potentially exacerbating the global energy crisis.
- Impressive Earnings Reports: UnitedHealth Group reported Q1 adjusted EPS of $9.23, significantly above the consensus of $6.57, leading to a stock price increase of over 7% and raising its full-year earnings forecast, showcasing strong performance in the health insurance sector.
See More
Marvell Technology to Benefit from Amazon-Anthropic Partnership Expansion
- Investment Scale: Anthropic announced it will invest over $100 billion in Amazon Web Services over the next decade to support the training and operation of its Claude large language models, aiming to secure up to 5 gigawatts of new capacity, significantly enhancing its competitive edge in AI technology.
- Key Role of Marvell: As a long-standing partner for Amazon's Trainium chips, Marvell supplies optical processors and other hardware, with analysts noting that the ramp-up of Trainium 3 will enhance Marvell's potential gains in Trainium 4, driving future growth for the company.
- Price Target Increase: RBC Capital Markets raised Marvell's price target from $115 to $170, reflecting optimistic market expectations for increased demand in AI chips and data center hardware, with current stock trading around $150, indicating strong market confidence.
- AI Market Outlook: With Anthropic's commitment to Amazon, demand for Marvell's ethernet switches and data processing units is expected to surge, and analysts believe this will lead to robust double-digit growth momentum, further solidifying its position in the AI hardware market.
See More
